期刊文献+

钒酸盐对糖尿病大鼠糖原的影响与cAMP的关系 被引量:1

The relationship between the changes of glycogen and cAMP under vanadates effect
下载PDF
导出
摘要 目的在链脲佐菌素(STZ)糖尿病大鼠模型观察钒酸盐(Va)对骨骼肌和肝脏糖原的影响与cAMP的关系。方法用正钒酸钠分别管饲正常对照大鼠和STZ致糖尿病大鼠,观测肝脏和骨骼肌的糖原与cAMP的变化趋势。结果与正常对照组比较,糖尿病骨骼肌糖原含量下降(P<0.01),肝糖原含量升高(P<0.01);Va使肌糖原上升47%(P<0.01),肝糖原下降50%(P<0.01),均恢复至正常水平,提示至少有部分肝糖原向骨骼肌转移。Va同时升高肝cAMP,降低骨骼肌cAMP,与糖尿病动物使用Va后肌肝糖原变化相反。结论本试验提示cAMP在Va导致的肝糖原向骨骼肌转移中发挥一定作用。 AIM To explore the relationship between changes of glycogen and cAMP induced by vanadate (Va). METHODS The contents of cAMP and glycogen were measured and their changes observed in liver and skeletal muscle isolated from normal control rats and streptozotocininduced diabetic rats, some of which were gavaged with sodium orthovanadate solution, others with physiological salt solution as controls. RESULTS ① Glycogen content decreased (P<001) and increased (P<001), respectively, in diabetic skeletal muscle and liver when compared to normal rats; after Va treatment (2 weeks), the former elevated by 47% (P<001), the latter reduced by 50% (P<001), both near to normal level. This suggested at least part of liver glycogen was transferred to skeletal muscle via blood circulation by Va; ② The change of cAMP in skeletal muscle and liver is opposite to that of glycogen in diabetic rat after Va treatment. CONCLUSION cAMP plays certain role in the mechanism of glycogen transfer from liver to skeletal muscle induced by Va.
出处 《中国药理学通报》 CAS CSCD 北大核心 1998年第2期151-153,共3页 Chinese Pharmacological Bulletin
关键词 糖尿病 药物疗法 钒酸盐 糖原 CAMP diabetes vanadate glycogen 3′,5′cyclic adenosine monophosphate
  • 相关文献

同被引文献15

  • 1Nielsen FH. Metal Ions in Biological Systems: Vanadium and Its Role in Life [M]. New York: Marcel Dekker, 1995.31543.
  • 2Cam MC, Brownsey RW, McNeill JH. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent? [J]. Can J Physiol Pharmacol, 2000,78(10):829-847.
  • 3Thompson KH,McNeill JH, Orvig C. Vanadium compounds as insulin mimics [J]. Chem Rev, 1999,99(9):2561-2572.
  • 4Brichard SM, Henquin JC. The role of vanadium in the management of diabetes [J]. Trends Pharmacol Sci, 1995,16(8):265-270.
  • 5Goldwaser I, Gefel D, Gershonov E, et al. Insulin-like effects of vanadium: basic and clinical implications [J]. J Inorg Biochem, 2000,80(1-2):21-25.
  • 6Rangel M, Tamura A, Fukushima C, et al. In vitro study of the insulin-like action of vanadyl-pyrone and -pyridinone complexes with a VO(O4) coordination mode [J]. J Biol Inorg Chem, 2001,6(2):128-132.
  • 7Mouzon SH, Peraldi P, Algengrin F, et al. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats [J]. Endocrinology, 1993,132(1):67-74.
  • 8Basnet P, Kadota S, Shimizu M, et al. Bellidifolin stimulates glucose uptake in rat 1 fibroblasts and ameliorates hyperglycemia in streptozotocin (STZ)-induced diabetic rats [J]. Planta Med, 1995,61(5):402-405.
  • 9Setyawati IA, Thompson KH, Yuen VG, et al. Kinetic analysis and comparison of uptake, distribution, and excretion of ^48V-labeled compounds in rats [J]. J Appl Physiol, 1998,84(2):569-575.
  • 10Takino T, Yasui H, Yoshitake A, et al. A new halogenated antidiabetic vanadyl complex bis (5-iodopicolinato) oxovanadium (Ⅳ): in vitro and in vivo insulinomimetic evaluations and metallokinetic analysis [J]. J Biol Inorg Chem, 2001,6(2):133-142.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部